$1.94B
Revenue
$-2.82B
Net Income
55.35%
Gross Margin
-158.13%
Op. Margin
$-5.29B
Free Cash Flow
| Breakdown | TTM (Dec 31, 2025) |
FY 2025 (Dec 31, 2025) |
FY 2024 (Dec 31, 2024) |
FY 2023 (Dec 31, 2023) |
FY 2022 (Dec 31, 2022) |
FY 2021 (Dec 31, 2021) |
|---|---|---|---|---|---|---|
| Total Revenue | $1.94B | $1.94B | $3.24B | $6.85B | $19.26B | $18.47B |
| Revenue Growth % | 0.0% | -39.9% | -52.7% | -64.4% | 4.3% | nan% |
| Cost of Revenue | $868.00M | $868.00M | $1.46B | $4.69B | $5.42B | $2.62B |
| Gross Profit | $1.08B | $1.08B | $1.77B | $2.15B | $13.85B | $15.85B |
| Gross Margin % | 55.3% | 55.3% | 54.8% | 31.5% | 71.9% | 85.8% |
| Operating Expenses | $5.02B | $5.02B | $7.18B | $11.09B | $9.84B | $5.17B |
| Research & Development | $3.13B | $3.13B | $4.54B | $4.84B | $3.29B | $1.99B |
| Operating Income | $-3.07B | $-3.07B | $-3.94B | $-4.24B | $9.42B | $13.30B |
| Operating Margin % | -158.1% | -158.1% | -121.9% | -61.9% | 48.9% | 72.0% |
| Interest Expense | - | $10.00M | $24.00M | $39.00M | $25.00M | $14.00M |
| Interest Income | $314.00M | $314.00M | $425.00M | $421.00M | $200.00M | $18.00M |
| Other Income/Expense | $-8.00M | $-8.00M | $-87.00M | $-124.00M | $-45.00M | $-29.00M |
| Income Before Tax | $-2.77B | $-2.77B | $-3.61B | $-3.94B | $9.57B | $13.29B |
| Income Tax Expense | $54.00M | $54.00M | $-46.00M | $772.00M | $1.21B | $1.08B |
| Net Income | $-2.82B | $-2.82B | $-3.56B | $-4.71B | $8.36B | $12.20B |
| Net Margin % | -145.2% | -145.2% | -110.0% | -68.8% | 43.4% | 66.1% |
| Basic EPS | nan | -7.26 | -9.28 | -12.33 | 21.26 | 30.31 |
| Diluted EPS | nan | -7.26 | -9.28 | -12.33 | 20.12 | 28.29 |
| Basic Shares Outstanding | 1.0M | 389.0M | 384.0M | 382.0M | 394.0M | 403.0M |
| Diluted Shares Outstanding | 1.0M | 389.0M | 384.0M | 382.0M | 416.0M | 431.0M |
| Breakdown | FY 2025 (Dec 31, 2025) |
FY 2024 (Dec 31, 2024) |
FY 2023 (Dec 31, 2023) |
FY 2022 (Dec 31, 2022) |
FY 2021 (Dec 31, 2021) |
|---|---|---|---|---|---|
| Cash & Cash Equivalents | $2.60B | $1.93B | $2.91B | $3.21B | $6.85B |
| Accounts Receivable | $184.00M | $358.00M | $892.00M | $1.39B | $3.17B |
| Inventory | $153.00M | $117.00M | $202.00M | $949.00M | $1.44B |
| Other Current Assets | $45.00M | $58.00M | $627.00M | $1.20B | $728.00M |
| Total Current Assets | $6.54B | $8.10B | $10.32B | $13.43B | $16.07B |
| Goodwill | $52.00M | $52.00M | - | - | - |
| Intangible Assets | $45.00M | $40.00M | - | - | - |
| Other Non-current Assets | $605.00M | $594.00M | $685.00M | $988.00M | $34.00M |
| Total Assets | $12.34B | $14.14B | $18.43B | $25.86B | $24.67B |
| Accounts Payable | $317.00M | $405.00M | $520.00M | $487.00M | $302.00M |
| Accrued Liabilities | $1.39B | $1.43B | $1.80B | $2.10B | $1.47B |
| Deferred Revenue | $99.00M | $153.00M | $568.00M | $2.04B | $6.25B |
| Other Current Liabilities | $185.00M | $221.00M | $66.00M | $249.00M | $225.00M |
| Total Current Liabilities | $1.99B | $2.21B | $3.02B | $4.92B | $9.13B |
| Long-term Debt | $590.00M | - | - | - | - |
| Deferred Tax Liabilities | $249.00M | $231.00M | - | - | - |
| Other Non-current Liabilities | $285.00M | $267.00M | $256.00M | $135.00M | $76.00M |
| Total Liabilities | $3.69B | $3.24B | $4.57B | $6.74B | $10.52B |
| Common Stock | - | - | - | - | - |
| Retained Earnings | $7.22B | $10.04B | $13.61B | $18.32B | $9.96B |
| Total Stockholders Equity | $8.65B | $10.90B | $13.85B | $19.12B | $14.14B |
| Total Liabilities & Equity | $12.34B | $14.14B | $18.43B | $25.86B | $24.67B |
| Breakdown | TTM (Dec 31, 2025) |
FY 2025 (Dec 31, 2025) |
FY 2024 (Dec 31, 2024) |
FY 2023 (Dec 31, 2023) |
FY 2022 (Dec 31, 2022) |
FY 2021 (Dec 31, 2021) |
|---|---|---|---|---|---|---|
| Net Income | $-2.82B | $-2.82B | $-3.56B | $-4.71B | $8.36B | $12.20B |
| Depreciation & Amortization | - | $211.00M | $185.00M | $617.00M | $348.00M | $232.00M |
| Stock-based Compensation | $843.00M | $483.00M | $429.00M | $305.00M | $226.00M | $142.00M |
| Deferred Income Tax | - | $10.00M | $-1.00M | $901.00M | - | - |
| Change in Receivables | $-746.00M | $-156.00M | $-534.00M | $-493.00M | $-1.79B | $1.78B |
| Change in Inventory | $164.00M | $34.00M | $-83.00M | $-747.00M | $-492.00M | $1.39B |
| Change in Payables | $-451.00M | $-92.00M | $-69.00M | $13.00M | $240.00M | $204.00M |
| Operating Cash Flow | $-4.87B | $-1.87B | $-3.00B | $-3.12B | $4.98B | $13.62B |
| Capital Expenditure | $429.00M | $192.00M | $1.05B | $707.00M | $400.00M | $284.00M |
| Acquisitions | - | - | - | $85.00M | - | - |
| Sales of Investments | $10.92B | $5.56B | $5.56B | $5.58B | $3.15B | $1.34B |
| Investing Cash Flow | $3.97B | $1.95B | $1.95B | $4.21B | $-5.18B | $-8.52B |
| Stock Issued | - | - | - | - | - | - |
| Stock Repurchased | - | $2.00M | - | $1.15B | $3.33B | $857.00M |
| Financing Cash Flow | $610.00M | $593.00M | $56.00M | $-1.38B | $-3.45B | $-873.00M |
| Net Change in Cash | $-283.00M | $668.00M | $-999.00M | $-289.00M | $-3.64B | $4.22B |
SEC Filing Format - Data shown as it appears in the Q3 2025 (10-Q) filing
Period ended: Sep 30, 2025
Condensed Consolidated Statements of Operations
| Description | Sep 30, 2025 | Sep 30, 2025 | ||
|---|---|---|---|---|
| Current | Prior Year | Current YTD | Prior Year YTD | |
| Total Revenue | $1.02B | $1.86B | $1.27B | $2.27B |
| Cost of Revenue | $207.00M | $514.00M | $416.00M | $725.00M |
| Operating Expenses | $1.28B | $1.93B | $3.48B | $4.97B |
| Research & Development | $801.00M | $1.14B | $2.36B | $3.42B |
| Operating Income | $-260.00M | $-70.00M | $-2.22B | $-2.70B |
| Interest Income | $73.00M | $103.00M | $244.00M | $334.00M |
| Other Income/Expense | - | $-12.00M | $4.00M | $-58.00M |
| Income Before Tax | $-187.00M | $21.00M | $-1.97B | $-2.42B |
| Income Tax Expense | $13.00M | $8.00M | $27.00M | $18.00M |
| Net Income | $-200.00M | $13.00M | $-2.00B | $-2.44B |
| Basic EPS | -0.51 | 0.03 | -5.15 | -6.37 |
| Diluted EPS | -0.51 | 0.03 | -5.15 | -6.37 |
| Basic Shares Outstanding | $390.00M | $385.00M | $388.00M | $383.00M |
| Diluted Shares Outstanding | $390.00M | $399.00M | $388.00M | $383.00M |
Condensed Consolidated Balance Sheets
| Description | Sep 30, 2025 | Dec 31, 2024 |
|---|---|---|
| Cash & Cash Equivalents | $1.13B | $1.93B |
| Accounts Receivable | $1.05B | $358.00M |
| Inventory | $332.00M | $117.00M |
| Other Current Assets | $716.00M | $599.00M |
| Total Current Assets | $6.60B | $8.10B |
| Other Non-current Assets | $530.00M | $594.00M |
| Total Assets | $12.13B | $14.14B |
| Accounts Payable | $267.00M | $405.00M |
| Accrued Liabilities | $1.18B | $1.43B |
| Deferred Revenue | $163.00M | $153.00M |
| Other Current Liabilities | $73.00M | $221.00M |
| Total Current Liabilities | $1.68B | $2.21B |
| Other Non-current Liabilities | $281.00M | $267.00M |
| Total Liabilities | $2.81B | $3.24B |
| Common Stock | - | - |
| Retained Earnings | $8.05B | $10.04B |
| Total Stockholders Equity | $9.33B | $10.90B |
| Total Liabilities & Equity | $12.13B | $14.14B |
Condensed Consolidated Statements of Cash Flows
| Description | Sep 30, 2025 | Sep 30, 2025 | ||
|---|---|---|---|---|
| Current | Prior Year | Current YTD | Prior Year YTD | |
| Net Income | $-200.00M | $13.00M | $-2.00B | $-2.44B |
| Stock-based Compensation | - | - | $370.00M | $325.00M |
| Change in Receivables | - | - | $703.00M | $672.00M |
| Change in Inventory | - | - | $213.00M | $208.00M |
| Change in Payables | - | - | $-114.00M | $-103.00M |
| Operating Cash Flow | - | - | $-2.80B | $-3.83B |
| Capital Expenditure | - | - | $153.00M | $529.00M |
| Sales of Investments | - | - | $4.63B | $4.65B |
| Investing Cash Flow | - | - | $1.99B | $2.49B |
| Financing Cash Flow | - | - | $12.00M | $59.00M |
| Net Change in Cash | - | - | $-795.00M | $-1.28B |
All values are in USD (United States Dollars). Data is sourced from SEC EDGAR 10-K filings.
Annual data represents full fiscal year results. FY = Fiscal Year ending.